Nuzenio

Against Replimune Group

Against Replimune Group news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-DemocratCarroll County Mirror-Democrat · Mon, 10 Aug 2026 16:00:00 GMTREPL Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Replimune Group, Inc. - PR NewswirePR Newswire · Mon, 10 Aug 2026 14:00:00 GMTBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Replimune Group Inc. (REPL) and Encourages Investors to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sun, 09 Aug 2026 18:56:02 GMTReplimune Group (REPL) Wins FDA Approval, Is The Valuation Still Too Rich? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:40:12 GMTREPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - StocktwitsStocktwits · Sat, 08 Aug 2026 03:13:33 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business WireBusiness Wire · Fri, 07 Aug 2026 21:07:00 GMTReplimune Group Investors Reminder for Upcoming Lawsuit Deadline - Intellectia AIIntellectia AI · Fri, 07 Aug 2026 19:56:24 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - barrons.combarrons.com · Fri, 07 Aug 2026 19:33:00 GMT

Timeline

Mon, 10 Aug 2026 16:00:00 GMTBronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
Mon, 10 Aug 2026 14:00:00 GMTREPL Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Replimune Group, Inc. - PR Newswire
Sun, 09 Aug 2026 18:56:02 GMTBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Replimune Group Inc. (REPL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Sun, 09 Aug 2026 13:40:12 GMTReplimune Group (REPL) Wins FDA Approval, Is The Valuation Still Too Rich? - simplywall.st
Sat, 08 Aug 2026 03:13:33 GMTREPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - Stocktwits
Fri, 07 Aug 2026 21:07:00 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.EconomyEconomy stories explain how money, jobs, prices, policy, trade, and business confidence affect daily life.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Against Replimune Group.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.